Researchers at Case Western Reserve University School of Medicine in Cleveland found those who had COVID-19 were more likely to be diagnosed with Alzheimer’s within a year of their initial infection.
Researchers analyzed EHR data on 6.2 million seniors treated at 68 healthcare organizations nationwide between Feb. 2, 2020, and May 30, 2021.
The 360-day risk for a new Alzheimer’s diagnosis was 0.68 percent among those who had COVID-19, compared to 0.47 percent for those who hadn’t been infected.
The study offers new evidence of a potential tie between COVID-19 and Alzheimer’s but does not prove that the virus causes the condition, The Washington Post reported Sept. 15. The study may also be limited by the potential for inaccurate Alzheimer’s diagnoses, study authors said.
Read the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
